1640-A

N/A

Report date: 2025/04/22 16:28:31
NME

Base Information

Drug Name1640-A
Drug Alias Name1640A1640-A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSusceptible anaerobic bacteria infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWeiduoan Pharmaceutical (Shandong) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWeiduoan Pharmaceutical (Shandong) Co Ltd
Inactive CompaniesN/A
Active IndicationsSusceptible anaerobic bacteria infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A